Jerrold B. Grossman - 07 Mar 2022 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Dr. Jerrold B. Grossman, by Brian Lenz as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
07 Mar 2022
Net transactions value
$0
Form type
4
Filing time
09 Mar 2022, 16:58:37 UTC
Previous filing
26 Oct 2021
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Award $0 +26,586 +10% $0.000000 287,450 07 Mar 2022 Direct F1, F2
holding ADMA Common Stock 22,857 07 Mar 2022 See footnote F3
holding ADMA Common Stock 31,381 07 Mar 2022 See footnote F4
holding ADMA Common Stock 38,294 07 Mar 2022 See footnote F5
holding ADMA Common Stock 175 07 Mar 2022 See footnote F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Employee Stock Option (right to buy) Award $0 +53,172 $0.000000 53,172 07 Mar 2022 Common Stock 53,172 $1.67 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
F2 Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 260,864 shares of common stock owned by the reporting person.
F3 These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
F4 These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
F5 These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
F6 These shares are owned by the reporting person's wife.
F7 The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.